Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female Subjects

TP0502-Pharmaco-Scintigraphic-Study and Amendment

NCT02306785 ·Status: COMPLETED ·Phase: PHASE1

TP0501 - Pharmaco-Scintigraphic-Study

NCT02306772 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

NCT07229950 ·Status: RECRUITING ·Phase: PHASE2

Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)

NCT00746447 ·Status: COMPLETED ·Phase: PHASE3

Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis

NCT01038739 ·Status: TERMINATED ·Phase: PHASE3

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

NCT00572585 ·Status: COMPLETED ·Phase: PHASE2

A Study for HSK47388 in Participants With Ulcerative Colitis

NCT07335055 ·Status: RECRUITING ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06589986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

NCT04857112 ·Status: COMPLETED ·Phase: PHASE2

TP0502-B-Pharmaco-Scintigraphic-Study

NCT02306798 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

NCT07062185 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

NCT06637631 ·Status: RECRUITING ·Phase: PHASE2

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis

NCT00449722 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

NCT07158242 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis

NCT01216280 ·Status: UNKNOWN ·Phase: PHASE2

Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)

NCT00747110 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares

NCT01120340 ·Status: COMPLETED ·Phase: PHASE3

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

NCT04767984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

NCT00545389 ·Status: COMPLETED ·Phase: PHASE2

Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis

NCT00767728 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects

NCT06175949 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

NCT01458951 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

NCT00787202 ·Status: COMPLETED ·Phase: PHASE2